Getinge AB (GETIb.ST)
242.00SEK
1 Aug 2013
1.00kr (+0.41%)
241.00kr
241.10kr
242.70kr
240.30kr
295,931
525,423
242.70kr
185.30kr
About
Overall
| Beta: | 0.70 |
| Market Cap (Mil.): | kr53,594.38 |
| Shares Outstanding (Mil.): | 222.38 |
| Dividend: | 4.15 |
| Yield (%): | 1.72 |
Financials
| GETIb.ST | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 26.00 | 27.50 | 37.76 |
| EPS (TTM): | 9.27 | -- | -- |
| ROI: | 6.66 | 9.26 | 18.76 |
| ROE: | 15.02 | 12.54 | 19.59 |
UPDATE 2-NORDIC STOCKS - Factors to watch on July 11
HELSINKI, July 11 - The following stocks may be affected by newspaper reports and other factors on Thursday:
NORDIC STOCKS - Factors to watch on July 11
HELSINKI, July 11 - The following stocks may be affected by newspaper reports and other factors on Thursday:
BRIEF-Getinge CEO says sees Q2 result better than Q2 2012
STOCKHOLM, April 17 - Getinge AB CEo told an analyst conference: * sees Q2 result better than Q2 2012
UPDATE 1-Getinge looks to emerging markets as Europe cuts weigh
* Sees FY2013 sales volumes flat or slightly up (Adds analyst comment, detail, background)
Getinge Q1 core profit falls, says profit outlook favourable
STOCKHOLM, April 17 - Swedish medical technology group Getinge posted on Wednesday a slightly larger fall than expected in first-quarter profits but said the earnings outlook for 2013 was favourable.
BRIEF-Getinge to consolidate production, cuts 150 jobs
STOCKHOLM, March 5 - Getinge AB : * Strengthens competitiveness through concentration of production units and
Getinge pushes back margin goal on weak demand, US tax
STOCKHOLM - Swedish medical technology group Getinge has pushed back its profit margin target by one to two years, blaming weaker-than-expected demand and a new tax in the United States.
UPDATE 1-Getinge pushes back margin goal on weak demand, US tax
* Targets Infection Control margin above 17 pct in 3-5 yrs
BRIEF-Getinge sets group EBITA margin target of 22 pct
STOCKHOLM, Feb 8 - Getinge AB : * Says with the aim of clearly and sustainably improve infection control's
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Thomson Reuters StreetEvents
|
$75.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

